News
August 21, 2017

The Food and Drug Administration declared that it would require strong new warnings that the combined use of opioid medications and benzodiazepines, a class of anti-anxiety medications can dangerously suppress breathing and cause coma or death. Thus, the stronger warning is required just to ensure the public that the combination can be dangerous.

FDA
4min read    
News
August 21, 2017

FDA announced that the safety labeling changes (SLC) program will be managed by the Center for Drug Evaluation and Research’s (CDER’s) Office of Communications (OCOMM). OCOMM has established a new “Drug Safety Labeling Changes (SLC)” database that provides these data to the public in downloadable and searchable formats.

FDA
4min read    
News
August 21, 2017

There is a hope on the very horizon for people suffering from low back pain. A relatively new procedure known as minimally invasive nerve-ablating procedure seems to be effective in treating some forms of back pain and may offer a new treatment option.

FDA
7min read    
News
August 21, 2017

Eli Lilly proved its victory for acquired FDA approval for blockbuster ixekizumab. There is a hope that will compete against a new wave of rival therapies for psoriasis. This drug would be sold as Taltz.

FDA
8min read    
News
August 21, 2017

Cardiovascular risks possess a great threat when one takes up the arthritis drugs. Thus, the researchers may be on their way to finding safer drugs for arthritis treatment that don't lead to potentially harmful cardiovascular side effects.

European Medicines Agency
5min read